EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders — A systematic review and Meta-Analysis

Alex J Murray, Clara S Humpston, Martin Wilson, Jack C Rogers, Mohammad Zia Ul Haq Katshu, Peter F Liddle, Rachel Upthegrove

Brain, Behavior, and Immunity · 2024-01 · 115 · 3-12

DOI: 10.1016/j.bbi.2023.09.017 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Brain, Behavior, and Immunity, 2024-01. Verfasst von Alex J Murray und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health and School of Psychology, University…. Hauptthemen laut MEDLINE: Schizophrenia, Psychotic Disorders. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NIHR Oxford Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress may contribute to declining course and poor outcomes in psychosis. However, in vivo Magnetic Resonance Spectroscopy studies yield disparate results due to clinical stage, sample demographics, neuroanatomical focus, sample size, and acquisition method variations. We investigated glutathione in brain regions from participants with psychosis, and the relation of glutathione to clinical features and spectroscopy protocols. Meta-analysis comprised 21 studies. Glutathione levels did not differ between total psychosis patients (N = 639) and controls (N = 704) in the Medial Prefrontal region (k = 21, d = -0.09, CI = -0.28 to 0.10, p = 0.37). Patients with stable schizophrenia exhibited a small but significant glutathione reduction compared to controls (k = 14, d = -0.20, CI = -0.40 to -0.00, p = 0.05). Meta-regression showed older studies had greater glutathione reductions, possibly reflecting greater accuracy related to spectroscopy advancements in more recent studies. No significant effects of methodological variables, such as voxel size or echo time were found. Reduced glutathione in patients with stable established schizophrenia may provide novel targets for precision medicine. Standardizing MRS acquisition methods in future studies may help address discrepancies in glutathione levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaPsychotic DisordersHumansBrainMagnetic Resonance SpectroscopyGlutathione

Stichwörter der Autor:innen

Brain imagingMagnetic Resonance SpectroscopySchizophrenia phases

Substanzen

Glutathione

Autor:innen und Institutionen

  • Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health and School of Psychology, University of Birmingham, Birmingham, United Kingdom. Electronic address: Axm166…
  • Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Department of Psychology, University of York, York, United Kingdom.
  • Centre for Human Brain Health and School of Psychology, University of Birmingham, Birmingham, United Kingdom.
  • Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health and School of Psychology, University of Birmingham, Birmingham, United Kingdom.
  • Institute of Mental Health, Division of Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, United Kingdom; Nottinghamshire Healthcare National Health Service Foundation Trust, Nottingham, Un…
  • Institute of Mental Health, Division of Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, United Kingdom.

Förderung

  • Medical Research Council
  • NIHR Oxford Biomedical Research Centre

Zitieren

APA

Murray, A. J., Humpston, C. S., Wilson, M., Rogers, J. C., Zia Ul Haq Katshu, M., Liddle, P. F., & Upthegrove, R. (2024). Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders — A systematic review and Meta-Analysis. Brain, Behavior, and Immunity, 115, 3-12. https://doi.org/10.1016/j.bbi.2023.09.017

Vancouver

Murray AJ, Humpston CS, Wilson M, Rogers JC, Zia Ul Haq Katshu M, Liddle PF, et al. Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders — A systematic review and Meta-Analysis. Brain, Behavior, and Immunity. 2024;115:3-12. doi:10.1016/j.bbi.2023.09.017

BibTeX
@article{Murray2024,
  author = {Murray, Alex J and Humpston, Clara S and Wilson, Martin and Rogers, Jack C and Zia Ul Haq Katshu, Mohammad and Liddle, Peter F and Upthegrove, Rachel},
  title = {Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders — A systematic review and Meta-Analysis},
  journal = {Brain, Behavior, and Immunity},
  year = {2024},
  volume = {115},
  pages = {3--12},
  doi = {10.1016/j.bbi.2023.09.017}
}
Kostenlos starten →